ROIV

ROIV

USD

Roivant Sciences Ltd. Common Shares

$19.870+0.320 (1.637%)

リアルタイム価格

Healthcare
バイオテクノロジー
英国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$19.550

高値

$19.890

安値

$19.315

出来高

9.01M

企業ファンダメンタルズ

時価総額

13.6B

業種

バイオテクノロジー

United Kingdom

取引統計

平均出来高

7.66M

取引所

NMS

通貨

USD

52週レンジ

安値 $8.73現在値 $19.870高値 $20.085

関連ニュース

GlobeNewswire

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.

もっと見る
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Analyst Upgrades

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25

Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.

もっと見る
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

もっと見る
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
GlobeNewswire

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to

もっと見る
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025